Test Price
2,800 AED✅ Home Collection Available
IFT122 Gene Cranioectodermal Dysplasia Type 1 Genetic Test in UAE – 2,800 AED – DNA Labs UAE
Executive Summary & Core Metrics
- Diagnostic Precision: 99.9% analytic sensitivity through ISO 9001:2015 certified NGS processing (Certificate: INT/EGQ/2509DA/3139).
- Integrated Logistics: Temperature-controlled cold-chain VIP mobile phlebotomy available daily 8 AM–11 PM; home collection for standard blood samples.
- Post-Test Consultation: Complimentary telephone genetic counseling to interpret results in clinical context.
- Insurance Facilitation: Direct billing verification via WhatsApp at +971 54 548 8731 before sample collection.
Test Overview & Methodology
This high-resolution genetic test sequences the entire coding region of the IFT122 gene to diagnose Cranioectodermal Dysplasia Type 1 (Sensenbrenner syndrome), a rare autosomal recessive ciliopathy characterized by skeletal, craniofacial, and ectodermal anomalies. Our Illumina-based next-generation sequencing (NGS) pipeline aligns reads to GRCh38 and includes copy-number variant detection, providing single-nucleotide resolution.
| Feature | Our Test (UAE Reference Lab) | Closest Alternative |
|---|---|---|
| Precision | Single-nucleotide resolution with copy-number variant detection via NGS | Targeted Sanger sequencing (misses deep intronic variants) |
| Methodology | Illumina NGS with bioinformatic pipeline aligned to GRCh38 | Capillary electrophoresis (Sanger) |
| Turnaround Time | 3–4 weeks (with genetic counseling integration) | 6–8 weeks (often outsourced internationally) |
Physician Insight & Safety Protocols
“As a clinical geneticist, I emphasize that the IFT122 NGS result must always be correlated with physical exam findings, growth parameters, and multisystem imaging. A negative result does not exclude the disease if clinical suspicion remains high. Genetic counseling before and after testing is mandatory for informed decision-making.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA No. 9294403)
Advisory Precautions
Important Medication Advisory
Do not discontinue any prescribed medication or supplement without consulting your ordering physician. This test does not replace therapeutic management.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Testing of minors without explicit parental/guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Exclusion: Patients who have not received mandatory pre-test genetic counselling (clinic policy aligned with international standards).
- Exclusion: Inadequate sample integrity (clotted blood, insufficient DNA yield).
- Red Flag: If the child develops acute respiratory distress, severe feeding difficulties, or seizures, seek emergency care immediately and inform the medical team of the pending genetic result.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of the IFT122 NGS test?
This NGS-based assay provides definitive molecular confirmation of Cranioectodermal Dysplasia Type 1 by sequencing the entire IFT122 gene, enabling accurate diagnosis, family planning, and multidisciplinary management. Results are interpreted in the context of clinical findings.
2. How is the sample collected, and does insurance cover the cost?
A VIP mobile phlebotomy service collects whole blood (2–5 mL in EDTA tube) or a single drop on an FTA card at your home. We verify insurance eligibility via WhatsApp at +971 54 548 8731 before billing, ensuring transparency.
3. Are there any data privacy risks under UAE law?
All genetic data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Data is processed exclusively within ISO-certified facilities and never shared without explicit consent.
UAE Regulatory & Data Privacy Adherence
Trust & Compliance Framework
DNA Labs UAE operates under DHA Facility License No. 1143 and adheres to all federal data protection laws. Your genetic information is anonymized, encrypted, and stored within the UAE. We comply with Federal Decree-Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019 on health ICT usage. No data is transferred internationally without explicit written consent.
Clinical & Logistical Metadata
| Test Name | IFT122 Gene Cranioectodermal Dysplasia Type 1 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA) or FTA card – VIP mobile phlebotomy & temperature-controlled cold-chain home collection available daily 8 AM–11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina platform with bioinformatics pipeline (GRCh38) |
| ICD-10-CM Code | Q87.8 (Other specified congenital malformation syndromes) |
| LOINC Code | 82939-0 (DNA sequencing gene panel) |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians